Sales and Marketing

Showing 15 posts of 11527 posts found.

Waggener Edstrom expands UK healthcare team

August 7, 2013 Medical Communications, Research and Development, Sales and Marketing Waggener Edstrom, foster

Comms agency Waggener Edstrom Worldwide (WE) has appointed Matt Foster to its healthcare practice as an account director. Foster will …

FDA makes GSK wait

August 6, 2013 Sales and Marketing FDA, GSK, albiglutide, diabetes

The FDA is making GlaxoSmithKline wait for a verdict on the manufacturer’s investigational type 2 diabetes treatment albiglutide, extending its …

GSK loses Tyverb patent

August 6, 2013 Sales and Marketing Cancer, GSK, GlaxoSmithKline, Tyverb

GlaxoSmithKline has received a knockback from authorities in India, who have revoked the patent on its breast cancer drug Tyverb. …

Roche breast cancer drug Perjeta rejected by NICE

August 6, 2013 Sales and Marketing Cancer, NICE, Perjeta, Roche

NICE is not recommending Roche’s next generation breast cancer drug Perjeta as a treatment for a particular type of advanced …

Bayer signs cancer vaccine research deal

August 6, 2013 Research and Development, Sales and Marketing Bayer, Vaccine, compugen

Bayer has entered into a new collaboration with Compugen to develop cancer vaccines aimed at helping the body fight off …

CRO Novum appoints vice president

August 6, 2013 Manufacturing and Production, Research and Development, Sales and Marketing alan copa, novum

Dr Alan Copa has joined contract research organisation Novum Pharmaceutical Research Services as vice president. “Dr. Copa brings a high …

Roche allows Valcyte access

August 5, 2013 Sales and Marketing HIV, Roche, valcyte

Roche has signed a deal with a United Nations initiative to open up access to an oral drug which is …

Charting the course of pharma contract manufacturing

August 5, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Taylor, contract manufacturing, pharma

It’s no secret that the pharmaceutical sector has been on a bumpy ride over the last few years.

NHS procurement drive ‘to save £1.5 billion’

August 5, 2013 Sales and Marketing NHS, UK, procurement

A blueprint for saving the NHS £1.5 billion has been launched by the government in a bid to ensure that …

Horizon Discovery hires non-executive director

August 5, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Gilham, Horizon Discovery

Research tools firm Horizon Discovery has announced the appointment of Dr Ian Gilham as a non-executive director. Gilham is currently …

Seroquel loss hits AstraZeneca

August 2, 2013 Sales and Marketing AstraZeneca, Q2, Seroquel, symbicourt

Loss of exclusivity on brands such as the antipsychotic Seroquel IR helped put a $500 million dent in AstraZeneca’s performance …

Targeted radiotherapy from 2018

August 2, 2013 Sales and Marketing Cameron, NHS, proton beam

Proton beam therapy, a targeted form of radiotherapy, is to be available at hospitals in Manchester and London from 2018 …

Sanofi makes two new senior hires

August 2, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi

Sanofi has announced the appointments of Carsten Hellmann and David Meeker to its executive committee team. Hellmann (pictured) joins Sanofi …

Actelion to buy Ceptaris

August 1, 2013 Sales and Marketing Actelion, FDA, ceptaris, valchlor

The US arm of Swiss speciality pharma group Actelion is in line to pay $250 million to buy private firm …

AstraZeneca signs $350m kidney deal

August 1, 2013 Sales and Marketing AstraZeneca, CKD, fibrogen, kidney

AstraZeneca has signed a deal with private biotech company FibroGen to develop a novel compound aimed at treating anaemia associated …
The Gateway to Local Adoption Series

Latest content